TrialAntimicrobial agents and chemotherapy2021

Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV.

Wendy Ankrom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.